Literature DB >> 178170

Decreased T-lymphocytes in patients with mammary cancer.

S E Keller, H L Ioachim, T Pearse, D M Siletti.   

Abstract

The levels of thymus-derived lymphocytes (T-cells) in samples of peripheral blood from 47 patients with carcinoma of the breast, 36 patients with benign mammary lesions, and 33 matched normal controls were determined. Results were analyzed with three statistical tests. It was found that the mean percentages of T-lymphocytes differed significantly among the three groups of patients (p less than 0.001). The mean percentages of rosette-forming lymphocytes were 72.8 for the normal group, 60.6 for patients with benign mammary lesions, and 45.1 for the patients with carcinoma. The finding of lower levels of T-lymphocytes in the peripheral blood of individuals with mammary cancer is of particular significance since all the patients in this study were otherwise in apparently good general health and undergoing no treatment.

Entities:  

Mesh:

Year:  1976        PMID: 178170     DOI: 10.1093/ajcp/65.4.445

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  9 in total

1.  Characterization of T-lymphocyte subpopulations infiltrating primary breast cancer.

Authors:  R Bilik; C Mor; B Hazaz; C Moroz
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

2.  Survival after mastectomy for breast cancer: predictive value of lymphocyte count and its change after mastectomy in patients with metastases to one to three axillary nodes.

Authors:  K K Meyer
Journal:  World J Surg       Date:  1978-05       Impact factor: 3.352

3.  Clonal analysis and in situ characterization of lymphocytes infiltrating human breast carcinomas.

Authors:  T L Whiteside; S Miescher; J Hurlimann; L Moretta; V von Fliedner
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

4.  Significance of tumour mass on T-lymphocyte levels in patients with gastrointestinal cancer.

Authors:  H S Shukla; R H Whitehead; L E Hughes
Journal:  Gut       Date:  1979-08       Impact factor: 23.059

5.  The Potential Role of MT and Vimentin Immunoreactivity in the Remodeling of the Microenvironment of Parotid Adenocarcinoma.

Authors:  Magdalena Dutsch-Wicherek; Agata Lazar; Romana Tomaszewska
Journal:  Cancer Microenviron       Date:  2010-12-15

6.  Importance of methodology in demonstrating depression of T-lymphocyte levels.

Authors:  R H Whitehead; G P Roberts; L E Hughes; J Thatcher
Journal:  Br J Cancer       Date:  1978-01       Impact factor: 7.640

7.  E-rosette-forming cells at 29 degrees C: an assay for the evaluation of the immune status of cancer patients.

Authors:  P C Quan; P Burtin
Journal:  Br J Cancer       Date:  1978-11       Impact factor: 7.640

8.  T lymphocyte subsets in the peripheral blood of patients with benign and malignant breast disease.

Authors:  D R McCluskey; A D Roy; W P Abram; W M Martin
Journal:  Br J Cancer       Date:  1983-02       Impact factor: 7.640

9.  Characterisation of breast cancer infiltrates using monoclonal antibodies to human leucocyte antigens.

Authors:  D J Rowe; P C Beverley
Journal:  Br J Cancer       Date:  1984-02       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.